Versant Capital Management’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.8K | Sell |
464
-5,988
| -93% | -$323K | ﹤0.01% | 1656 |
|
|
2026
Q1 | $337K | Sell |
6,452
-880
| -12% | -$52.8K | 0.03% | 389 |
|
|
2025
Q4 | $431K | Sell |
7,332
-231
| -3% | -$14K | 0.05% | 250 |
|
|
2025
Q3 | $421K | Buy |
7,563
+371
| +5% | +$19.9K | 0.06% | 243 |
|
|
2025
Q2 | $370K | Buy |
7,192
+7,047
| +4,860% | +$354K | 0.06% | 256 |
|
|
2025
Q1 | $8.5K | Sell |
145
-618
| -81% | -$41.9K | ﹤0.01% | 1798 |
|
|
2024
Q4 | $55K | Buy |
763
+198
| +35% | +$14.5K | 0.01% | 547 |
|
|
2024
Q3 | $45.2K | Buy |
565
+15
| +3% | +$1.13K | 0.01% | 496 |
|
|
2024
Q2 | $39.4K | Buy |
550
+514
| +1,428% | +$37.8K | 0.01% | 462 |
|
|
2024
Q1 | $2.53K | Hold |
36
| – | – | ﹤0.01% | 1275 |
|
|
2023
Q4 | $2.78K | Buy |
36
+18
| +100% | +$1.19K | ﹤0.01% | 1190 |
|
|
2023
Q3 | $1.23K | Sell |
18
-2
| -10% | -$158 | ﹤0.01% | 1472 |
|
|
2023
Q2 | $1.63K | Buy |
20
+12
| +150% | +$965 | ﹤0.01% | 1447 |
|
|
2023
Q1 | $586 | Hold |
8
| – | – | ﹤0.01% | 1566 |
|
|
2022
Q4 | $663 | Hold |
8
| – | – | ﹤0.01% | 1392 |
|
|
2022
Q3 | $1K | Buy |
8
+4
| +100% | +$346 | ﹤0.01% | 1344 |
|
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1638 |
|
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1624 |
|
|
2021
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 1355 |
|
|
2021
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 1594 |
|
|
2021
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1593 |
|
|
2021
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1601 |
|
|
2020
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1521 |
|
|
2020
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 1492 |
|
|
2020
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1535 |
|
|
2020
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1656 |
|
|
2019
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1569 |
|
|
2019
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 1580 |
|
|
2019
Q2 | $0 | Sell |
4
-12
| -75% | -$605 | ﹤0.01% | 1686 |
|
|
2019
Q1 | $0 | Hold |
16
| – | – | ﹤0.01% | 1730 |
|
|
2018
Q4 | $0 | Hold |
16
| – | – | ﹤0.01% | 1641 |
|
|
2018
Q3 | $0 | Hold |
16
| – | – | ﹤0.01% | 1649 |
|
|
2018
Q2 | $0 | Hold |
16
| – | – | ﹤0.01% | 1638 |
|
|
2018
Q1 | $0 | Hold |
16
| – | – | ﹤0.01% | 1649 |
|
|
2017
Q4 | $0 | Hold |
16
| – | – | ﹤0.01% | 1640 |
|
|
2017
Q3 | $0 | Hold |
16
| – | – | ﹤0.01% | 1570 |
|
|
2017
Q2 | $0 | Hold |
16
| – | – | ﹤0.01% | 1542 |
|
|
2017
Q1 | $0 | Hold |
16
| – | – | ﹤0.01% | 1535 |
|
|
2016
Q4 | $0 | Hold |
16
| – | – | ﹤0.01% | 1521 |
|
|
2016
Q3 | $0 | Sell |
16
-16
| -50% | -$439 | ﹤0.01% | 1482 |
|
|
2016
Q2 | $0 | Sell |
32
-16
| -33% | -$411 | ﹤0.01% | 1435 |
|
|
2016
Q1 | $1K | Hold |
48
| – | – | ﹤0.01% | 1282 |
|
|
2015
Q4 | $1K | Buy |
+48
| New | +$1.09K | ﹤0.01% | 1284 |
|
Other funds holding TECH
HI
Versant Capital Management's TECH Position: Q2 2026 in Review
Versant Capital Management reduced its Bio-Techne (TECH) stake by 93% in Q2 2026, selling an estimated $323K and leaving 464 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1656.
Versant Capital Management first reported a position in TECH in Q4 2015 and has held it in 43 quarters since. The position peaked at $431K in Q4 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Versant Capital Management held 464 shares of Bio-Techne worth $32.8K as of Q2 2026.
- Versant Capital Management sold 5,988 Bio-Techne shares in Q2 2026, an estimated $323K.
- Bio-Techne made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1656 holding.
- Versant Capital Management first reported a position in Bio-Techne in Q4 2015 and has held it in 43 quarters since.
- Versant Capital Management's Bio-Techne position peaked at $431K in Q4 2025.
- 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.